Status:
COMPLETED
Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure
Lead Sponsor:
Hamad Medical Corporation
Conditions:
COVID-19 Patients
Hypoxemic Respiratory Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigator hypothesis is that early implementation of early, awake prone position for patients with COVID-19 pneumonia requiring oxygen therapy will reduce the need for escalation of respiratory...
Detailed Description
The world health organization has designated the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) as an ongoing pandemic and a public health emergency of international concern. The disease...
Eligibility Criteria
Inclusion
- All adults with suspected or confirmed COVID-19 and hypoxemia respiratory failure.
- SPO2 less than 94% or Oxygen requirment of more than 5 liters.
- Requiring oxygen therapy in Hospital\< 24 hours
Exclusion
- Clinical assessment for immediate intervention.
- PF\<50
- SF\<90
- RR\>60bpm
- Hemodynamics instability with need for vasopressors.
- MSOF
- Age\<18
- Pregnancy
- Impaired LOC, agitation or lack of cooperative patient.
- BMI\>40
- Unstable spine or pelvis
- Abdominal wound
- Pnemothorax
- Any injury or illness that may be worsened or result in pain as a result of prone position.
- DNAR
- Any contraindicaton to prone position.
Key Trial Info
Start Date :
May 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04853979
Start Date
May 16 2021
End Date
July 12 2021
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Qatar, 3050